RxDoctor Payments Data

Sanjay Nandurkar, MD

Interventional Pain Medicine · Lancaster, SCNPI 1902905581

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Boston Scientific at 46.3% of the total. Reporting peaked in 2019 at $1,129 and has fallen 93.5% since, to $73 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in SC, where the typical reported total is $3,940.

$3,940in general payments, 2019–2025

Across 102 payments — averaging $38.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Nevro Corp.$1K
  • Vertos Medical, Inc.$378
  • Stimwave Technologies Incorporated$273
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$121
  • Medtronic$90
  • plus $255 from 10 others

What the payments were for

  • Food & beverage$3,940100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,940 in reported general payments places this provider in the 50th percentile of 38 interventional pain medicine providers in South Carolina.

See all interventional pain medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$227,186
Medicare patients
307
Services billed
6,480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,616$61,211
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen2,078$52,214
Gabapentin1,365$19,589
Xtampza ErOxycodone Myristate12$12,161
MovantikNaloxegol Oxalate27$11,465
Morphine Sulfate ErMorphine Sulfate233$11,181
Fentanyl43$7,264
Naloxone Hcl98$6,519
Lidocaine63$5,817
Cyclobenzaprine Hcl460$5,465
Oxycodone Hcl270$5,124
BelbucaBuprenorphine Hcl12$5,055
Diclofenac Sodium216$4,633
Tizanidine Hcl332$4,145
Baclofen272$3,202

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Lancaster

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →